Nanjing Pharmaceutical Group Company Limited Class ASSE: 600713

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Indicative Announcement on Suspension of Conversion of "NANJING PHARMACEUTICAL Convertible Bonds" During the Implementation of Interim Dividend Distribution for 2026

Sep 4, 2026 · Issued by Nanjing Pharmaceutical Group Company Limited Class A via Shanghai Stock Exchange

Indicative Announcement on Suspension of Conversion of "NANJING PHARMACEUTICAL Convertible Bonds" During the Implementation of Interim Dividend Distribution for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Nanjing Pharmaceutical Group Company Limited Class A

"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased with Certain Temporarily Idle Raised Funds and Continued Cash Management by the CompanySep 3
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Issuance Results of the 11th Tranche of Super Short-term Commercial Paper for 2026Aug 29
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on the Departure of a Non-Independent DirectorAug 22
"NANJING PHARMACEUTICAL GROUP COMPANY LIMITED"Announcement on Redemption upon Maturity of Cash Management Products Purchased by the Company's Subsidiary with Part of Temporarily Idle Raised Funds and Continued Cash ManagementJul 16

All Nanjing Pharmaceutical Group Company Limited Class A news releases